Business Description
Zhejiang Orient Gene Biotech Co Ltd
ISIN : CNE100003RM8
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.57 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.92 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.65 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -37.4 | |||||
3-Year Book Growth Rate | 44.9 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.3 | |||||
9-Day RSI | 40.89 | |||||
14-Day RSI | 41.74 | |||||
6-1 Month Momentum % | 17.01 | |||||
12-1 Month Momentum % | -7.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.09 | |||||
Quick Ratio | 3.71 | |||||
Cash Ratio | 3.33 | |||||
Days Inventory | 302.08 | |||||
Days Sales Outstanding | 107.62 | |||||
Days Payable | 332.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 152 | |||||
Shareholder Yield % | -2.1 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 41.03 | |||||
Operating Margin % | -62.63 | |||||
Net Margin % | -71.14 | |||||
FCF Margin % | -163.76 | |||||
ROE % | -8.05 | |||||
ROA % | -6.74 | |||||
ROIC % | -13.55 | |||||
ROC (Joel Greenblatt) % | -25.72 | |||||
ROCE % | -8.04 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.41 | |||||
PB Ratio | 0.9 | |||||
Price-to-Tangible-Book | 1.01 | |||||
EV-to-EBIT | -4.82 | |||||
EV-to-EBITDA | -4.82 | |||||
EV-to-Revenue | 3.59 | |||||
EV-to-FCF | -2.33 | |||||
Price-to-Projected-FCF | 0.47 | |||||
Price-to-Net-Current-Asset-Value | 1.93 | |||||
Price-to-Net-Cash | 2.63 | |||||
Earnings Yield (Greenblatt) % | -20.75 | |||||
FCF Yield % | -21.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zhejiang Orient Gene Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 825.599 | ||
EPS (TTM) (Â¥) | -2.93 | ||
Beta | 1.5 | ||
Volatility % | 39.83 | ||
14-Day RSI | 41.74 | ||
14-Day ATR (Â¥) | 1.328826 | ||
20-Day SMA (Â¥) | 31.5635 | ||
12-1 Month Momentum % | -7.06 | ||
52-Week Range (Â¥) | 24.4 - 41.49 | ||
Shares Outstanding (Mil) | 201.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zhejiang Orient Gene Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zhejiang Orient Gene Biotech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Zhejiang Orient Gene Biotech Co Ltd Frequently Asked Questions
What is Zhejiang Orient Gene Biotech Co Ltd(SHSE:688298)'s stock price today?
When is next earnings date of Zhejiang Orient Gene Biotech Co Ltd(SHSE:688298)?
Does Zhejiang Orient Gene Biotech Co Ltd(SHSE:688298) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |